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Caforio et al. (1) in this issue of the Journal provide addi- 
tional evidence for the concept that concomitant skeletal 
muscle abnormalities are frequent in patients with cardiomy- 
opathy. Their study provides indirect but suggestive support 
for the view that the skeletal muscle findings are not attrib- 
utable to a neurogenic origin, inadequate systemic blood 
flow or disuse atrophy due to cardiac failure. Consequently, 
if their observations and those of others (2-5) are confirmed 
in larger patient groups, cardiomyopathy may ultimately be 
considered to be part of a spectrum of generalized myopa- 
thies. As a corollary, if future studies indicate that the 
observed skeletal muscle abnormalities are specific for car- 
diomyopathy and do not routinely accompany cardiac dis- 
ease of other origins (e.g., ischemic or valvular disease), 
then skeletal muscle biopsy or quantitative electromyogra- 
phy may prove a useful adjunctive diagnostic aid in patients 
who have otherwise unexplained cardiac findings (e.g., 
cardiac arrhythmias in association with an “apparently 
normal heart”). 
Syndromes exhibiting concomitant skeletal and cardiac 
myopathy. The best recognized associations of skeletal 
muscle and cardiac dysfunction are the genetically deter- 
mined muscular dystrophies. For example, cardiomyopathy 
is nearly always present in patients with Duchenne muscular 
dystrophy (6), although cardiac symptoms are rare until the 
terminal stage of this illness. Cardiomyopathic findings are 
also associated with both myotonic dystrophy and limb- 
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girdle dystrophy. In patients with the former condition, 
cardiac dysfunction is usually marked by conduction defects 
and occasionally arrhythmias, whereas in the latter, more 
heterogeneous group of patients, symptoms and signs of 
congestive heart failure as well as cardiac arrhythmias have 
been reported (6). 
Several other relatively uncommon but distinct clinical 
syndromes exhibit both skeletal and cardiac muscle involve- 
ment. For example, type 2 glycogen storage disease (alpha- 
1,4_glucosidase deficiency) is associated with massive accu- 
mulation of abnormal glycogen in skeletal and cardiac 
muscle. In addition, Friedreich’s ataxia, an autosomal reces- 
sive degenerative disorder of the cerebellum and spinal cord, 
has been associated with hypertrophic cardiomyopathy (6- 
8). In the latter condition, both disturbances of ventricular 
function and cardiac arrhythmias contribute importantly to 
the late clinical picture. In another group of disorders, 
characterized as mitochondrial myopathies (6,9), muscle 
biopsy reveals excessively numerous and large or bizarre 
mitochondria in association with a variety of biochemical 
abnormalities. Kearns-Sayre syndrome, the most widely 
recognized of these disorders, includes conduction system 
involvement among its many features (10). Similarly, cardio- 
myopathy has been associated with certain uncommon con- 
genital skeletal muscle myopathies. For example, myotubu- 
lar myopathy has been associated with a variety of 
cardiovascular disturbances including congestive heart fail- 
ure, right ventricular hypertrophy and arrhythmias. 
Association of skeletal myopathy and cardiomyopathy. 
Although cardiomyopathy is not usually a prominent pre- 
senting feature of patients with neuromuscular disorders, 
physicians experienced in the care of these patients have 
recognized the possibility of cardiac involvement. In con- 
trast, physicians treating patients with cardiovascular dis- 
ease generally have not been alert to the possibility that 
overt symptomatic cardiomyopathy may be associated with, 
and perhaps be a manifestation of, a generalized myopathy. 
Nonetheless, several investigators have raised this issue. 
For example, in their evaluation of six patients with cardio- 
myopathy, Shafiq et al. (2) found distinct histochemical and 
electron microscopic abnormalities in skeletal muscle, al- 
though light microscopic findings were normal. Similarly, 
among 11 patients with hypertrophic cardiomyopathy stud- 
ied by Smith et al. (3), 8 exhibited abnormalities of skeletal 
muscle by histochemical or electron microscopic evalua- 
tions. Mitochondrial abnormalities ranging from minor ultra- 
structural changes to prominent mitochondrial proliferation 
and structural alterations were present. In addition, in- 
creased numbers of lipid droplets were detected in affected 
muscle fibers. 
Recently, Dunnigan et al. (4) studied histologic and 
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biochemical features of skeletal muscle biopsy specimens in 
10 young patients in whom cardiac arrhythmias appeared to 
be the initial manifestation of cardiomyopathy. None of the 
patients exhibited symptomatic skeletal myopathy, and only 
one patient manifested findings of symptomatic left ventric- 
ular dysfunction. In all 10 patients, skeletal muscle biopsy 
specimens were normal when stained with hematoxylin- 
eosin, but were abnormal on electron microscopic assess- 
ment. An increased frequency of lipid droplets was uni- 
formly present, with endomysial fibrosis evident in 9 of the 
10 cases. In addition, although fasting serum carnitine and 
short- and long-chain acylcarnitine concentrations were nor- 
mal in 9 of the 10 patients, 9 had an apparent decrease in 
skeletal muscle long-chain acylcarnitine. The presence of 
endomysial fibrosis in these patients suggested that the 
skeletal muscle abnormality was relatively long standing and 
was not secondary to an acute cardiac process. The in- 
creased lipid droplets and decreased skeletal muscle acyl- 
carnitme levels, although nonspecific, suggested the poten- 
tial for a systemic metabolic defect of lipid utilization. 
findings in normal subjects or patients having other forms of 
cardiac disease; 2) differences among various reports regard- 
ing involvement of type 1 and type 2 fibers need reconcilia- 
tion; 3) the apparently similar association of skeletal muscle 
abnormalities with both dilated and hypertrophic cardiomy- 
opathies, conditions that are conventionally believed to have 
different causes, needs clarification. 
Finally, the potential contribution of disorderedfatty acid 
metabolism needs further study. Whether disordered metab- 
olism of this type represents the important functional 
disturbance in certain cardiomyopathies or an epiphe- 
nomenologic “footprint” indicative of other intracellular 
disturbances remains speculative, but it is clearly a subject 
of potentially fruitful future research. 
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